Greater Claims Leeway Proposed By Health Freedom Protection Act
This article was originally published in The Tan Sheet
Executive Summary
A bill introduced in Congress Nov. 9 would "prevent FDA from disallowing structure function claims that include terms that refer to signs or symptoms of disease so long as the disease itself is not mentioned.